AVITA Medical Inc

RCEL

$8.57

Closing

▼-4.57%

1D

▼-37.54%

YTD

Market cap

$221.10M

52 week high

$21.70

52 week low

$8.46

Volume

58,238

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$221.10M

Analysts' Rating

BUY

Price Target (Mean)

24.5

Total Analysts

5

P/E

Operating Margin

-68.20%

Beta

1.53

Revenue Growth (Annual)

0.00%

52 week high

$21.70

52 week low

$8.46

Div. Yield

%

EPS Annual Growth

-17.07

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

AVITA Medical Inc. is a regenerative medicine company. The Company is engaged in the development and commercialization of devices and autologous cellular therapies for skin restoration. The Company’s RECELL System is a single use (disposable), stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators to achieve the disaggregation and delivery of skin cells. The platform technology of the RECELL System allows for the preparation and delivery of Spray-On Skin Cells, an autologous cellular suspension comprised of the patient’s own skin cells necessary to regenerate natural healthy epidermis. These Spray-On Skin Cells are prepared at the point of care, providing a new way to treat thermal burns, other wounds, skin injuries or defects of the skin. The RECELL System is designed to be used at the point of care alone or in combination with autografts, depending on the depth of the burn injury.